This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI HUMAN FACTOR VII
catalog :
MCA4680G
quantity :
0.2 mg
price :
371 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
RFF-VII/2
reactivity :
human
application :
western blot, ELISA
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA4680G
Description :
MOUSE ANTI HUMAN FACTOR VII
Specificity :
FACTOR VII
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB*,R,E
ApplicationTypes :
Western Blotting,ELISA,Radioimmunoassays
Clone :
RFF-VII/2
Quantity :
0.2 mg
QuantityValue :
0.2
QuantityType :
mg
GOAccessions :
GO:0005886,GO:0005509,GO:0001948,GO:0017187,GO:0043687,GO:0050927,GO:0051897,GO:0002690,GO:0004252,GO:0005788,GO:0005796,GO:0006508,GO:0006916,GO:0007598,GO:0010641
GOTerms :
bacterial inner membrane,cell membrane,cytoplasmic membrane,GO:0005904,inner endospore membrane,juxtamembrane,plasma membrane lipid bilayer,plasmalemma,calcium ion storage activity,activation of leukocyte chemotaxis,positive regulation of immune cell chemotaxis,positive regulation of leucocyte chemotaxis,stimulation of leukocyte chemotaxis,up regulation of leukocyte chemotaxis,upregulation of leukocyte chemotaxis,up-regulation of leukocyte chemotaxis,blood coagulation factor activity,cisternal lumen,endoplasmic reticulum cisterna,ER cisterna,ER lumen,GO:0016022,ATP-dependent proteolysis,peptidolysis,apoptosis inhibitor activity,positive regulation of platelet-derived growth factor receptor signalling pathway,posttranslational amino acid modification,post-translational amino acid modification,posttranslational modification,post-translational modification,posttranslational protein modification,PTM,activation of positive chemotaxis,stimulation of positive chemotaxis,up regulation of positive chemotaxis,upregulation of positive chemotaxis,up-regulation of positive chemotaxis,activation of protein kinase B signaling cascade,positive regulation of AKT signaling cascade,positive regulation of AKT signalling cascade,positive regulation of PKB signaling cascade,positive regulation of PKB signalling cascade,positive regulation of protein kinase B signalling cascade,stimulation of protein kinase B signaling cascade,up regulation of protein kinase B signaling cascade,upregulation of protein kinase B signaling cascade,up-regulation of protein kinase B signaling cascade
UniprotAccessions :
P08709
Gene :
F7
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2155
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0mg/ml
ProductForm :
Purified IgG - liquid
PriceGBP :
265
PriceEUR :
371
PriceUSD :
371 USD
PriceCHF :
404.39
PriceSEK :
3899
PriceNOK :
3973
PriceDKK :
2768
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.